The association of GABRB2 SNPs with cognitive function in schizophrenia

  • Qingqing Zhang
  • Xiuzhen Zhang
  • Sijia Song
  • Shuai Wang
  • Xin Wang
  • Hao Yu
  • Hongying Han
  • Xuan Zhou
  • Gongying LiEmail author
  • Yili WuEmail author
Original Paper


Cognitive impairment is one of the core symptoms of schizophrenia. Multiple domains of cognition are affected in patients with schizophrenia, which has a major effect on the functional outcome. Recent studies indicate that SNPs in the gamma-aminobutyric acid type A receptor beta 2 subunit (GABRB2) gene are associated with the risk of schizophrenia, however, the effect of these SNPs on cognitive function in patients with schizophrenia has not been explored. In this study, we first performed a case–control analysis of three SNPs (rs187269 allele A vs. G, rs252944 allele C vs. G, and rs194072 allele A vs. G) in 100 patients and 90 controls, then conducted a meta-analysis and found the SNP rs194072 was associated with schizophrenia (OR = 0.86, P = 0.0119), and survived after Bonferroni correction. The haplotype analysis suggested that the haplotype ACA, comprising the three SNPs (rs187269, rs252944 and rs194072) was also significantly associated with schizophrenia (P = 0.049).Then, we performed an association analysis of three SNPs (rs187269, rs252944 and rs194072) in GABRB2 gene with cognitive performance in patients with first episode schizophrenia. We found that the allele G of rs187269 in the GABRB2 gene was significantly associated with better cognitive flexibility (P = 0.005), a major aspect of executive function, in patients with first episode schizophrenia. The haplotype ACA was significantly associated with cognitive flexibility in patients with schizophrenia (P = 0.023). Our study showed that SNPs in GABRB2 may have a significant effect on cognitive function in patients with schizophrenia, suggesting that modulating GABRB2 may have therapeutic potential to improve cognitive function of patients with schizophrenia.


GABRB2 SNPs Schizophrenia Cognitive function 


Author contributions

QZ, XZ, SS and HH performed the cognitive test in patients and collected the blood samples; QZ and XW performed DNA extraction and amplification experiments; HY, SW and XZ analyzed the data; QZ, HY, and SW wrote the paper. GL and YW conceived the experiments and wrote the paper. All authors reviewed the manuscript.


The present work was funded by National Natural Science Foundation of China (No. 81571334 and No. 81771147), Natural Science Foundation of Shandong Province (ZR2011HM023, ZR2016HM30), research project of teaching reform in undergraduate colleges and universities in Shandong Province(2015M049), the development of medical science and technology project of Shandong Province(2011HZ011), science and technology project of higher education of Shandong Province(J10LF01) and postgraduate education innovation program of Shandong Province(SDYY15012).

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

Supplementary material

406_2019_985_MOESM1_ESM.docx (26 kb)
Supplementary material 1 (DOCX 26 KB)


  1. 1.
    Bhugra D (2005) The global prevalence of schizophrenia. PLoS Med 2(5):e151CrossRefGoogle Scholar
  2. 2.
    Pfammatter M, Junghan UM, Brenner HD (2006) Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophr Bull 32(Suppl 1):S64–S80CrossRefGoogle Scholar
  3. 3.
    Harris AW et al (2017) Web-based cognitive remediation improves supported employment outcomes in severe mental illness: randomized controlled trial. JMIR Ment Health 4(3):e30CrossRefGoogle Scholar
  4. 4.
    Lichtshtein D et al (1978) Gamma-aminobutyric acid (GABA) in the CSF of schizophrenic patients before and after neuroleptic treatment. Br J Psychiatry 132:145–148CrossRefGoogle Scholar
  5. 5.
    Tsang SY et al (2013) Social cognitive role of schizophrenia candidate gene GABRB2. PLoS One 8(4):e62322CrossRefGoogle Scholar
  6. 6.
    Yeung RK et al (2018) Gabrb2-knockout mice displayed schizophrenia-like and comorbid phenotypes with interneuron-astrocyte-microglia dysregulation. Transl Psychiatry 8(1):128CrossRefGoogle Scholar
  7. 7.
    Lo WS et al (2004) Association of SNPs and haplotypes in GABAA receptor beta2 gene with schizophrenia. Mol Psychiatry 9(6):603–608CrossRefGoogle Scholar
  8. 8.
    Zhao C et al (2012) Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disorders. Schizophr Res 134(2–3):260–266CrossRefGoogle Scholar
  9. 9.
    Lo WS et al (2007) GABRB2 association with schizophrenia: commonalities and differences between ethnic groups and clinical subtypes. Biol Psychiatry 61(5):653–660CrossRefGoogle Scholar
  10. 10.
    Yu Z et al (2006) Analysis of GABRB2 association with schizophrenia in German population with DNA sequencing and one-label extension method for SNP genotyping. Clin Biochem 39(3):210–218CrossRefGoogle Scholar
  11. 11.
    Petryshen TL et al (2005) Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol Psychiatry 10(12):1074–1088, 1057CrossRefGoogle Scholar
  12. 12.
    Zhang T et al (2018) Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium. PLoS One 13(6):e0198690CrossRefGoogle Scholar
  13. 13.
    Allen NC et al (2008) Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40(7):827CrossRefGoogle Scholar
  14. 14.
    Shi J, Gershon ES, Liu C (2008) Genetic associations with schizophrenia: meta-analyses of 12 candidate genes. Schizophr Res 104(1–3):96–107CrossRefGoogle Scholar
  15. 15.
    Pun FW et al (2011) Imprinting in the schizophrenia candidate gene GABRB2 encoding GABA(A) receptor beta(2) subunit. Mol Psychiatry 16(5):557–568CrossRefGoogle Scholar
  16. 16.
    Zhao C et al (2006) Two isoforms of GABA(A) receptor beta2 subunit with different electrophysiological properties: differential expression and genotypical correlations in schizophrenia. Mol Psychiatry 11(12):1092–1105CrossRefGoogle Scholar
  17. 17.
    Grant DA, Berg EA (1993) Wisconsin card sorting test (WCST)Google Scholar
  18. 18.
    Redick TS, Engle RW (2010) Working memory capacity and attention network test performance. Appl Cognit Psychol 20(5):713–721CrossRefGoogle Scholar
  19. 19.
    Tombaugh TN (2004) Trail making test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 19(2):203–214CrossRefGoogle Scholar
  20. 20.
    Gazzaniga et al (2009) Cognitive neuroscience: the biology of the mind. W. W. Norton, New York, 87–90Google Scholar
  21. 21.
    Duijkers JC, Vissers CT, Egger JI (2016) Unraveling executive functioning in dual diagnosis. Front Psychol 7:979CrossRefGoogle Scholar
  22. 22.
    Borkowska A et al (2009) The wisconsin card sorting test and the N-back test in mild cognitive impairment and elderly depression. World J Biol Psychiatry 10(4–3):870–876Google Scholar
  23. 23.
    Drapier D et al (2008) Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task. Biol Psychiat 64(6):513–520CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institute of Mental HealthJining Medical UniversityJiningChina
  2. 2.Department of PsychiatryJining Medical UniversityJiningChina
  3. 3.Department of PsychiatryLinyi Municipal Mental CenterLinyiChina
  4. 4.Department of PsychiatryJining Psychiatric HospitalJiningChina
  5. 5.Department of PsychiatryRizhao Mental Health CenterRizhaoChina
  6. 6.Shandong Key Laboratory of Behavioral MedicineJiningChina
  7. 7.Department of PsychiatryThe Third Affiliated Hospital of SunYat-Sen UniversityGuangzhouChina
  8. 8.Jining Medical UniversityJiningChina

Personalised recommendations